Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 2Tumor-Agnostic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Kaposi 1Sarcoma 1Neoplasms 1Nasopharyngeal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Hodgkin Disease 1Head and Neck Neoplasms 1Castleman Disease 1Carcinoma, Adenoid Cystic 1

Interventions

pembrolizumab 33Cetuximab 16Cisplatin 10Radiotherapy 8Paclitaxel 8Docetaxel 8atezolizumab 7Fluorouracil 7cemiplimab 6Drug Therapy 6budigalimab 5Gemcitabine 5Cyclophosphamide 5Blood Specimen Collection 5trametinib 4Pemetrexed 4Nivolumab 4Magnetic Resonance Spectroscopy 4Bleomycin 4Bevacizumab 4palbociclib 3fludarabine 3durvalumab 3dabrafenib 3avelumab 3Trastuzumab 3Oxaliplatin 3Interleukin-2 3Indocyanine Green 3Immunotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Nelfinavir × Head & Neck × Clear all
NCT02080416 2016-06-10

Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Terminated
1 enrolled
GastrointestinalHead & NeckLymphoidSarcoma

Castleman Disease, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Neoplasms, Sarcoma, Sarcoma, Kaposi, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡